Enhanced neuronal death from focal ischemia in AMPA-receptor transgenic mice

Molecular Brain Research

Volumn 52, Issue 2, 1997, Pages 235-241

  Le, Dean ^a,b   Das, Saumya ^a   Wang, Yanming F ^c   Yoshizawa, Toshihiro ^a   Sasaki, Yasnory F ^a   Takasu, Mari ^a   Nemes, Adriana ^d   Mendelsohn, Monica ^d   Dikkes, Pieter ^c   Lipton, Stuart A ^a,c   Nakanishi, Nobuki ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d The New York Presbyterian Hospital   (United States)

Author keywords

AMPA receptor; Animal model; Excitotoxicity; Focal ischemia; GluR2 flip; Transgenic mouse

Indexed keywords

AMPA RECEPTOR; EXCITATORY AMINO ACID RECEPTOR;

ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ELECTRIC CURRENT; LD 50; MIDDLE CEREBRAL ARTERY; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; STROKE; TRANSGENIC MOUSE;

ALTERNATIVE SPLICING; ANIMALS; BRAIN; CELL DEATH; CEREBRAL CORTEX; CROSSES, GENETIC; DISEASE SUSCEPTIBILITY; FEMALE; HETEROZYGOTE; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; NEOCORTEX; NEURONS; POLYMERASE CHAIN REACTION; RECEPTORS, AMPA; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

ANIMALIA; MUS MUSCULUS;

EID: 0031574239     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00261-1     Document Type: Article

References (23)

1. [1] H. Benveniste, J. Drejer, A. Schousboe, N.H. Diemer, Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis, J. Neurochem. 43 (1984) 1369-1374.
2. [2] A.M. Buchan, H. Li, S. Cho, W.A. Pusinelli, Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats, Neurosci. Lett. 132 (1991) 255-258.
3. [3] A.M. Buchan, A. Slivka, D. Xue, The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke, Brain Res. 574 (1992) 171-177.
4. [4] R. Bullock, H. Fujisawa, The role of glutamate antagonists for the treatment of CNS injury, J. Neurotrauma (1992) S443-S462.
5. [5] D.W. Choi, Ionic dependence of glutamate neurotoxicity, J. Neurosci. 7 (1987) 369-379.
6. [6] D.W. Choi, Glutamate neurotoxicity and diseases of the nervous system, Neuron 1 (1988) 623-634.
7. [7] Division of Chronic Disease Control and Community Intervention. Cardiovascular disease surveillance: stroke, 1980-89 (Atlanta Centers for Disease Control and Prevention, 1994).
8. [8] M. Fisher, Potentially effective therapies for acute ischemic stroke, Eur. Neurol. 35 (1995) 3-7.
9. [9] J.R.P. Geiger, T. Melcher, D.-S. Koh, B. Sakman, P.M. Seeburg, P. Jonas, H. Monyer, Relative abundance of subunit mRNAs determines gating and Ca permeability of AMPA receptors in principal neurons and interneurons in rat CNS, Neuron 15 (1995) 193-204.
10. [10] M. Hollmann, S. Heinemann, Cloned glutamate receptors, Ann. Rev. Neurosci. 17 (1994) 31-108.
11. [11] Z. Huang, P.L. Huang, N. Panahian, T. Dalkara, M.C. Fishman, M.A. Moskowitz, Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase, Science 265 (1994) 1883-1885.
12. [12] J.Y. Koh, D.W. Choi, Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay, J. Neurosci. Methods 20 (1987) 83-90.
13. [13] S.A. Lipton, P.A. Rosenberg, Mechanisms of disease: Excitatory amino acids as a final common pathway for neurological disorders, New Engl. J. Med. 330 (1994) 613-622.
14. [14] E.Z. Longa, P.R. Weinstein, S. Carlson, R. Cummins, Reversible middle cerebral artery occlusion without craniectomy in rats, Stroke 20 (1989) 84-91.
15. [15] M. Mayford, J. Wang, E.R. Kandel, T.J. O'Dell, CamKII regulates the frequency response function of hippocampal synapses for the production of both LTD and LTP, Cell 81 (1995) 891-904.
16. [16] B. Meldrum, J. Garthwaite, Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci. 11 (1990) 379-387.
17. [17] J. Mosbacher, R. Schoepfer, H. Monyer, N. Burnashev, P.M. Seeburg, J.P. Ruppersberg, A molecular determinant for submillisecond desensitization in glutamate receptors, Science 266 (1994) 1059-1061.
18. [18] J.W. Olney, Inciting excitotoxic cytocide among central neurons, Adv. Exp. Med. Biol. 203 (1986) 631-645.
19. [19] H. Pollard, A. Heron, J. Moreau, Y. Ben-Ari, M. Khrestchatisky, Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia, Neuroscience 57 (1993) 545-554.
20. [20] M.J. Sheardown, E.O. Hielson, A.J. Hansen, P. Jacobsen, T. Honore, 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia, Science 247 (1990) 571-574.
21. [21] S.E. Smith, B.S. Meldrum, Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI52466, after focal ischemia in the rat, Stroke 23 (1992) 861-864.
22. [22] B. Sommer, K. Keinanen, T.A. Verdoorn, W. Wisden, N. Burnashev, A. Herb, M. Kohler, T. Takagi, B. Sakmann, P.H. Seeburg, Flip and flop: a cell-specific functional switch in glutamate-operated channels of the central nervous system, Science 249 (1990) 1580-1584.
23. [23] T.A. Verdoorn, N. Burnashev, H. Monyer, P.H. Seeburg, B. Sakmann, Structural determinants of ion flow through recombinant glutamate receptor channels, Science 252 (1991) 1715-1718.